"Hematologic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of the blood and blood forming tissues.
| Descriptor ID |
D006402
|
| MeSH Number(s) |
C15.378
|
| Concept/Terms |
Hematologic Diseases- Hematologic Diseases
- Disease, Hematologic
- Diseases, Hematologic
- Hematologic Disease
- Blood Diseases
- Blood Disease
- Disease, Blood
- Diseases, Blood
- Hematological Diseases
- Disease, Hematological
- Diseases, Hematological
- Hematological Disease
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Diseases".
This graph shows the total number of publications written about "Hematologic Diseases" by people in this website by year, and whether "Hematologic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematologic Diseases" by people in Profiles.
-
Perioperative Approach to Anticoagulants and Hematologic Disorders. Anesthesiol Clin. 2016 Mar; 34(1):101-25.
-
Cellular therapies supplement: strategies for improving transplant efficiency in the context of cellular therapeutics. Transfusion. 2011 Nov; 51 Suppl 4:125S-137S.
-
Cigarette smoking and outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1004-11.
-
Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia. Leuk Lymphoma. 2003 Mar; 44(3):477-81.
-
ZD0473 treatment in lung cancer: an overview of the clinical trial results. Eur J Cancer. 2002 Dec; 38 Suppl 8:S13-8.
-
Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586). Am J Clin Oncol. 2000 Aug; 23(4):371-5.
-
Convulsive disorders: toxicity of anticonvulsants. Clin Neuropharmacol. 1991 Apr; 14(2):97-115.